MYC and medulloblastoma: Treatment with EPZ015666 resulted in downregulation of both PRMT5 and MYC protein expression, suppression of cell growth, and induction of apoptosis in MYC-driven medulloblastoma cells associated with G1/S cell cycle arrest (Fig. 5D).